Market Cap

Nova Mentis Life Science Corp Market Capitalization:

C$2.9 Million

CAD as of Jan. 1, 2024

US$2.2 Million

business Nova Mentis Life Science Corp Company Profile

Nova Mentis Life Science Corp Main Stock Listing

CSE: NOVA

Market Capitalization History of Nova Mentis Life Science Corp

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Nova Mentis Life Science Corp market cap

Date Market Cap YoY Change
Jan. 1, 2024 C$2.9 M -77.21%
Jan. 1, 2023 C$12.9 M 80.00%
Jan. 1, 2022 C$7.2 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +181.22%

$10,000 in June 2023 would now be $28,122 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Nova Mentis Life Science Corp Categories

Canada languages Healthcare languages Drug Manufacturers—Specialty & Generic
Canada Healthcare Canada Drug Manufacturers—Specialty & Generic

Stocks & Indices

Nova Mentis Life Science Corp has the following listings and related stock indices.


Stock: CSE: NOVA

Stock: FSX: HN3Q

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.